エクソソーム技術の世界市場レポート 2024年

エクソソーム技術の市場規模は近年急激に拡大しています。2023年の6,000万米ドルから2024年には7,000万米ドルへと、CAGR26.7％で拡大します。過去の期間に見られた拡大は、治療法の進歩、分離技術の進歩、研究資金の増加、再生医療の探求、臨床試験の開始によるものです。

エクソソーム技術市場の成長が予想される背景には、慢性疾患の有病率の増加があります。慢性疾患は、3ヶ月以上持続する持続的または長期的な影響を特徴とし、エクソソーム技術の需要を生み出しています。これらの技術は、疾患特異的バイオマーカーの同定、エクソソームカーゴ分析による疾患進行のモニタリング、標的ドラッグデリバリーの促進、慢性疾患における免疫調節において重要な役割を果たしています。例えば、2023年1月の統計によると、米国では50歳以上で1つ以上の慢性疾患を持つ人の数が99.5％増加し、2020年の7,152万2,000人から2050年には1億4,266万人に達すると予測されています。オーストラリアでは、2022年7月にオーストラリア保健福祉研究所（AIHW）が発表したところによると、人口の47％、1,160万人が10種類の慢性疾患のうち少なくとも1つに罹患していると推定されています。したがって、慢性疾患の有病率の上昇は、エクソソーム技術市場の成長を促進すると予想されます。

北米は、2023年のエクソソーム技術市場で最大の地域です。アジア太平洋は、予測期間中、エクソソーム技術世界市場レポートにおいて最も急成長する地域となる見込みです。エクソソーム技術市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 市場促進要因・市場抑制要因
  • 市場促進要因
  • 市場抑制要因
• 市場規模と成長実績、2018～2023年
• 市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

• 世界のエクソソーム技術市場、エクソソームの種類別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• カーゴ
• 非カーゴ
• 世界のエクソソーム技術市場、細胞源別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• HEK293細胞
• 間葉系幹細胞（MSC）
• 血小板
• 赤血球
• ナチュラルキラー細胞
• その他
• 世界のエクソソーム技術市場、用途別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 治療
• 診断
• 世界のエクソソーム技術市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 医療提供者
• 製薬企業・バイオテクノロジー企業
• その他

第7章 地域および国の分析

• 世界のエクソソーム技術市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界のエクソソーム技術市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• エクソソーム技術市場の競合情勢
• エクソソーム技術市場の企業プロファイル
  • AEGLE Therapeutics
  • Aruna Bio Inc.
  • Carmine Therapeutics Inc.
  • Exosome Diagnostics Inc.
  • Creative Biolabs Inc.

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

“Exosome Technologies Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on exosome technologies market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for exosome technologies? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The exosome technologies market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

• 1) By Exosome Type: Loaded Cargos; Non-Cargo
• 2) By Cell Source: HEK293 Cells; Mesenchymal Stem Cells (MSCs); Platelets; Erythrocytes; Natural Killer Cells; Other Cell Sources
• 3) By Application: Therapeutics; Diagnostics
• 4) By End-Users: Health Care Providers; Pharmaceutical And Biotechnology Companies; Other End-Users
• Companies Mentioned: AEGLE Therapeutics; Aruna Bio Inc.; Carmine Therapeutics Inc.; Exosome Diagnostics Inc.; Creative Biolabs Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Exosome technologies involve the utilization of exosomes, which are small extracellular vesicles originating from endosomes, across diverse fields such as regenerative medicine, biotechnology, and biomedical research. This technology holds promise for applications in diagnostics, especially in liquid biopsy-based diagnostics and projects focused on discovering biomarkers. Exosomes, due to their unique characteristics, can serve as diagnostic biomarkers for the early identification of diseases.

Two primary types of exosome technologies are loaded cargo and non-cargo. Loaded cargo pertains to exosomes that have been modified to carry specific cargos, including therapeutic agents, employing passive or active loading methods. These engineered exosomes are derived from various cell sources such as HEK293 cells, mesenchymal stem cells (MSCs), platelets, erythrocytes, natural killer cells, and others. They find applications in both therapeutics and diagnostics, with end-users encompassing healthcare providers, pharmaceutical and biotechnology companies, and other entities.

The exosome technologies market research report is one of a series of new reports from The Business Research Company that provides exosome technologies market statistics, including exosome technologies industry global market size, regional shares, competitors with an exosome technologies market share, detailed exosome technologies market segments, market trends and opportunities, and any further data you may need to thrive in the exosome technologies industry. This exosome technologies market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The exosome technologies market size has grown exponentially in recent years. It will grow from $0.06 billion in 2023 to $0.07 billion in 2024 at a compound annual growth rate (CAGR) of 26.7%. The expansion observed in the historical period can be credited to progress in therapeutics, advancements in isolation techniques, increased funding for research, exploration of regenerative medicine, and the initiation of clinical trials.

The exosome technologies market size is expected to see exponential growth in the next few years. It will grow to " $0.18 billion in 2028 at a compound annual growth rate (CAGR) of 27.0%.

The anticipated growth in the forecast period can be ascribed to advancements in regulatory frameworks, innovations in biomedical engineering, proliferation of clinical trials, development in regenerative medicine, and the growth of nanotechnology integration. Major trends expected in the forecast period include advancements in therapeutics, applications in diagnostics, integration of nanotechnology, a surge in research funding, and the development of isolation techniques.

The anticipated growth in the exosome technologies market is driven by the increasing prevalence of chronic diseases. Chronic diseases, characterized by persistent or long-lasting effects lasting three months or more, are on the rise, creating a demand for exosome technologies. These technologies play a crucial role in identifying disease-specific biomarkers, monitoring disease progression through exosome cargo analysis, facilitating targeted drug delivery, and immune modulation in chronic conditions. For instance, statistics from January 2023 indicate that the number of individuals aged 50 years and older with one or more chronic illnesses in the United States is projected to increase by 99.5%, reaching 142.66 million by 2050, up from 71.522 million in 2020. In Australia, an estimated 47% of the population, or 11.6 million individuals, are affected by at least one of the ten selected chronic ailments, as reported by the Australian Institute of Health and Welfare (AIHW) in July 2022. Hence, the escalating prevalence of chronic diseases is expected to drive the growth of the exosome technologies market.

The upward trajectory of healthcare expenditure is poised to propel the exosome technologies market. Healthcare expenditure, encompassing the total financial outlay on healthcare services, goods, and activities within a specific healthcare system or economy over a defined period, serves as a pivotal factor in advancing exosome technologies. This financial support fuels research and development initiatives, facilitates reimbursement for clinical applications, promotes the market for chronic disease management, and supports infrastructure development. Notably, in the UK, healthcare spending experienced a 9.4% increase in nominal terms and a 9.7% rise in real terms between 2020 and 2021. The total healthcare expenditure in the UK reached $367.25 billion (£280.7 billion) in 2021, with pharmaceutical expenditure standing at $51.84 billion (£39.6 billion). Moreover, preventive care spending surged to $45.93 billion (£35.1 billion) in 2021, more than doubling from 2020. Thus, the escalating healthcare expenditures contribute to the growth of the exosome technologies market.

The exosome technology market is witnessing a prominent trend in the adoption of advanced exosome characterization technologies. Companies within this market are integrating new technologies to maintain their competitive standing. For example, in August 2022, Creative Biolabs Inc., a biotech company based in the United States, introduced the NanosightTM platform for exosome characterization, leveraging Nanosight technology. Nanosight is a nanoparticle tracking analysis (NTA) technique enabling the visualization and quantification of exosomes based on their size and concentration. By offering this platform, Creative Biolabs intends to equip researchers with sophisticated tools for the comprehensive characterization and analysis of exosomes, facilitating a deeper understanding of their properties and functions.

Major players in the exosome technology sector are embracing a strategic partnership approach, seeking to capitalize on synergies and expedite progress in this dynamically evolving field. Strategic partnerships involve companies leveraging each other's strengths and resources to achieve mutually beneficial outcomes. In June 2023, RoosterBio Inc., a biotechnology firm based in the United States, forged a partnership with Repligen, a life sciences company focused on bioprocessing. This collaboration aims to accelerate the development of scalable and cost-effective exosome bioprocessing solutions, ultimately enhancing accessibility to exosome-based therapies for patients.

In November 2021, Lonza, a Switzerland-based biotechnology research company, completed the acquisition of Codiak BioSciences' exosome manufacturing facility for $65 million. This strategic move by Lonza is geared toward fortifying its presence in the exosome market and meeting the escalating demand for exosome-based therapeutics and diagnostics. Codiak BioSciences, a U.S.-based biopharmaceutical company, specializes in the development of exosome-based therapeutics.

Major companies operating in the exosome technologies market report are AEGLE Therapeutics, Aruna Bio Inc., Carmine Therapeutics Inc., Exosome Diagnostics Inc., Creative Biolabs Inc., Danaher Corporation, OmniSpirant Limited, Thermo Fisher Scientific Inc., Fujifilm Holdings Corporation, Anjarium Biosciences, NOVADIP Biosciences S.A., Exopharm Ltd., Organicell Regenerative Medicine Inc., Evox Therapeutics, Direct Biologics, ExoCan Healthcare Technologies Pvt. Ltd., ExoCoBio, ExonanoRNA LLC, ILIAS Biologics Inc., Illumina Inc., Invitrix Therapeutics, XOStem Inc., VivaZome Therapeutics Pty Ltd., Aethlon Medical Inc., Capricor Therapeutics, Codiak BioSciences, Exogenus Therapeutics, Exovita Biosciences, HansaBioMed Life Sciences, Hitachi Chemical Advanced Therapeutics Solutions

North America was the largest region in the exosome technologies market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global exosome technologies market report during the forecast period. The regions covered in the exosome technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the exosome technologies market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The exosome technologies market consists of revenues earned by entities by providing exosome technologies services such as vaccine development, biomarker production, exosome-based diagnostic testing, and therapeutic development. The market value includes the value of related goods sold by the service provider or included within the service offering. The market value includes the value of related goods sold by the service provider or included within the service offering. The exosome technologies market consists of sales of exosome isolation kits, purification reagents, characterization tools, analysis kits, and exosome-based therapeutic products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Exosome Technologies Market Characteristics

3. Exosome Technologies Market Trends And Strategies

4. Exosome Technologies Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Exosome Technologies Market Size and Growth

• 5.1. Global Exosome Technologies Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Exosome Technologies Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Exosome Technologies Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Exosome Technologies Market Segmentation

• 6.1. Global Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Loaded Cargos
• Non-Cargo
• 6.2. Global Exosome Technologies Market, Segmentation By Cell Source, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• HEK293 Cells
• Mesenchymal Stem Cells (MSCs)
• Platelets
• Erythrocytes
• Natural Killer Cells
• Other Cell Sources
• 6.3. Global Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Therapeutics
• Diagnostics
• 6.4. Global Exosome Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Health Care Providers
• Pharmaceutical And Biotechnology Companies
• Other End-Users

7. Exosome Technologies Market Regional And Country Analysis

• 7.1. Global Exosome Technologies Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Exosome Technologies Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Exosome Technologies Market

• 8.1. Asia-Pacific Exosome Technologies Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Exosome Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Exosome Technologies Market

• 9.1. China Exosome Technologies Market Overview
• 9.2. China Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Exosome Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Exosome Technologies Market

• 10.1. India Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Exosome Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Exosome Technologies Market

• 11.1. Japan Exosome Technologies Market Overview
• 11.2. Japan Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Exosome Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Exosome Technologies Market

• 12.1. Australia Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Exosome Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Exosome Technologies Market

• 13.1. Indonesia Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Exosome Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Exosome Technologies Market

• 14.1. South Korea Exosome Technologies Market Overview
• 14.2. South Korea Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Exosome Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Exosome Technologies Market

• 15.1. Western Europe Exosome Technologies Market Overview
• 15.2. Western Europe Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Exosome Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Exosome Technologies Market

• 16.1. UK Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Exosome Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Exosome Technologies Market

• 17.1. Germany Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Exosome Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Exosome Technologies Market

• 18.1. France Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Exosome Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Exosome Technologies Market

• 19.1. Italy Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Exosome Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Exosome Technologies Market

• 20.1. Spain Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Exosome Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Exosome Technologies Market

• 21.1. Eastern Europe Exosome Technologies Market Overview
• 21.2. Eastern Europe Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Exosome Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Exosome Technologies Market

• 22.1. Russia Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Exosome Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Exosome Technologies Market

• 23.1. North America Exosome Technologies Market Overview
• 23.2. North America Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Exosome Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Exosome Technologies Market

• 24.1. USA Exosome Technologies Market Overview
• 24.2. USA Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Exosome Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Exosome Technologies Market

• 25.1. Canada Exosome Technologies Market Overview
• 25.2. Canada Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Exosome Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Exosome Technologies Market

• 26.1. South America Exosome Technologies Market Overview
• 26.2. South America Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Exosome Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Exosome Technologies Market

• 27.1. Brazil Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Exosome Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Exosome Technologies Market

• 28.1. Middle East Exosome Technologies Market Overview
• 28.2. Middle East Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Exosome Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Exosome Technologies Market

• 29.1. Africa Exosome Technologies Market Overview
• 29.2. Africa Exosome Technologies Market, Segmentation By Exosome Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Exosome Technologies Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Exosome Technologies Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Exosome Technologies Market Competitive Landscape And Company Profiles

• 30.1. Exosome Technologies Market Competitive Landscape
• 30.2. Exosome Technologies Market Company Profiles
  • 30.2.1. AEGLE Therapeutics
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Aruna Bio Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Carmine Therapeutics Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Exosome Diagnostics Inc.
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Creative Biolabs Inc.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Exosome Technologies Market Competitive Benchmarking

32. Global Exosome Technologies Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Exosome Technologies Market

34. Exosome Technologies Market Future Outlook and Potential Analysis

• 34.1 Exosome Technologies Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Exosome Technologies Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Exosome Technologies Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer